Skip to main content
Fig. 1 | Chinese Journal of Cancer

Fig. 1

From: Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial

Fig. 1

Flowchart of patients with cancer-related pain who were randomized to receive either controlled-release oxycodone/naloxone (OXN-CR) or controlled-release oxycodone (OX-CR). aThe patient was found to have significant structural/functional abnormalities of the gastrointestinal tract which was deemed to be not appropriate for oral medicine administration

Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us